P
Power Law company profile
Peloton Therapeutics
Biotech & Life Sciences · Dallas, United States · Founded 2010 Unicorn
Patent intelligence
$15M patent portfolio · 18 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$15M
1.5% of valuation · 3× smaller than top peer Haihe Biopharma ($45M)
18 active patent families
Where Peloton Therapeutics innovates
Pharmaceutical drugDiseasePharmaceutical SubstancesMedicinal chemistryAmide
Above peer median on Strategic · Below peer median on Market
Quality vs same-sector peers
Peloton Therapeutics on the five Patsnap quality dimensions
Peloton Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Peloton Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Peloton Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Peloton Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.